Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Gene discovery could curb malaria spread
Only the female mosquito bites people and animals to feed on blood and spread disease.

'Femaleless' gene can be manipulated to prevent female mosquitoes from developing.

Scientists at The Pirbright Institute have discovered a new gene that determines the sex of malaria mosquitoes.

Only the female mosquito bites people and animals to feed on blood and spread disease.
Researchers say the new gene, named femaleless, can be manipulated to prevent female mosquitoes from developing - and could therefore provide a new means for the genetic control of mosquito populations. 

The study was led by scientists from the Vector Molecular Biology Group and published in Current Biology

In the study, researchers first identified femaleless in the mosquito Anopheles gambiae, a primary malaria carrier in Africa. Their experiments revealed that by decreasing the gene expression in mosquito eggs, females develop a more male-like appearance and cannot mate or feed on blood. 

The scientists also discovered that femaleless is exclusive to mosquito species belonging to the genus Anopheles, which is solely responsible for transmitting human malaria. The gene was detected in all Anopheles species studied, and its genetic sequence proved to be similar in different species. 

Dr Jaroslaw Krzywinski, head of the Vector Molecular Biology Group at Pirbright, explains: “We first investigated femaleless because we suspected it would have a role in sex determination, but it was unexpected that knockdown of the gene’s expression would lead to female lethality. 

“This gene is highly conserved in sequence and function in various Anopheles species and, as such, provides an excellent universal target to eliminate females of major malaria vector species, enabling the control of their populations. We hope that this discovery could help us to tackle one of the most devastating insect-borne diseases in the world.”

According to the World Health Organisation, there were an estimated 229 million clinical cases of malaria in 2019 and more than 400,000 deaths globally. Children under five are the most vulnerable group affected by the disease, accounting for 67 per cent of all malaria deaths in 2019. 

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.